And just to add, the PR’s save about 3-6 months in review time. They are valuable if you are competing for marketing approval with a competitors review process.
First to market.
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial, page-51
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.07 |
Change
-0.020(0.39%) |
Mkt cap ! $1.567B | |||
| Open | High | Low | Value | Volume |
| $5.07 | $5.08 | $4.89 | $2.540M | 506.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4456 | $5.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 4500 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |